Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.48 |
| ▸ | NMUR2 | Q9GZQ4 | 7/20 | 0.47 |
| ▸ | NMUR1 | Q9HB89 | 6/20 | 0.47 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.46 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.45 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.45 |
| ▸ | F2R | P25116 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29611481 | 0.95 | CAPN1 (0.51) | APLNROPRM1OPRK1NMUR2NMUR1 | |
| SCHEMBL29611888 | 0.94 | NTSR2 (0.47) | APLNROPRM1OPRK1NMUR2NMUR1 | |
| SCHEMBL29611384 | 0.94 | NMUR2 (0.51) | APLNROPRM1OPRK1NMUR2NMUR1 | |
| SCHEMBL29611754 | 0.93 | CAPN1 (0.49) | APLNROPRM1OPRK1CAPN1 | |
| SCHEMBL29611815 | 0.92 | NTSR1 (0.51) | NMUR2NMUR1NTSR2NTSR1F2R | |
| SCHEMBL29611522 | 0.92 | CAPN1 (0.54) | APLNROPRM1OPRK1CAPN1 | |
| SCHEMBL29611596 | 0.91 | CAPN1 (0.57) | OPRM1OPRK1NMUR2NMUR1CAPN1 | |
| SCHEMBL29611474 | 0.90 | NTSR2 (0.48) | OPRM1NMUR2NMUR1CAPN1NTSR2 | |
| SCHEMBL29611889 | 0.89 | CAPN1 (0.48) | OPRM1OPRK1CAPN1NTSR2NTSR1 | |
| SCHEMBL29611576 | 0.89 | CAPN1 (0.48) | APLNROPRM1OPRK1CAPN1NTSR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12419824-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2025-09-23 | — | — | US | disclosed |
| US-20220183950-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2022-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220183950-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | TYR, TELO2, MTX2 | APLNR 974/4885OPRM1 1087/4885OPRK1 3322/4885 |
| US-12419824-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | TYR, TELO2, MTX2 | APLNR 974/4885OPRM1 1087/4885OPRK1 3322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.